Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.
BARDA
Jump to navigation
Jump to search
 BARDA     | |
|---|---|
| Formation | December 2006 |
| Parent organization | US/Department/Health and Human Services |
| Headquarters | Washington D.C., USA |
| Sponsor of | CARB-X, Emergent Biosolutions, Eli Lilly, Luminex, Siemens Healthineers, Sonica Health, Colorado State University, Phillips North America, University of Connecticut,  AstraZeneca, Janssen Research & Development, Merck, Moderna, Novavax, Pfizer, Sanofi, GlaxoSmithKline, Univercells |
| Membership | • Gary L. Disbrow • Linda C. Lambert • Robert Johnson (BARDA) • Joffrey Benford • Nikki Bratcher-Bowman • Tracey Trautman • Brian Mazanec • Jonathan N. Greene • Arlene Joyner • Steven A. Adams |
| Responsible for bioterrorism "medical countermeasures" (i.e. the actual biological weapons, like "vaccines") | |
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of "medical countermeasures" (i.e. the actual biological weapons, like "vaccines"), principally against "bioterrorism", including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.[1][2]
Projects
Some of the Covid project partners BARDA has funded, 2020 only.[3]
Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.
